RecruitingNot ApplicableNCT06705153

The Effect of Laughter Yoga on Symptom Severity, Depression-anxiety-stress, Sleep Quality and Quality of Life in Patients with Irritable Bowel Syndrome

The Effect of Laughter Yoga in Patients with Irritable Bowel Syndrome: a Randomized Controlled Trial

Sponsor

Ataturk University

Enrollment

56 participants

Start Date

Dec 4, 2024

Study Type

INTERVENTIONAL

Conditions

Irritable Bowel Syndrome

Summary

The study will be conducted to evaluate the effect of laughter yoga on symptom severity, depression, anxiety, stress, sleep and quality of life in patients with Irritable Bowel Syndrome (IBS). The following hypotheses will be tested in this study: H1: Laughter yoga reduces symptom severity in patients with IBS. H2: Laughter yoga reduces depression, anxiety and stress in patients with IBS. H3: Laughter yoga improves sleep quality in patients with IBS. H4: Laughter yoga improves quality of life in patients with IBS.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether laughter yoga sessions, conducted via video call, can reduce the severity of irritable bowel syndrome (IBS) symptoms and improve depression, anxiety, stress, sleep, and overall quality of life in IBS patients. **You may be eligible if...** - You have been diagnosed with IBS according to established clinical criteria (Rome IV) - Your IBS symptoms are moderate to severe (score of 75 or above on the IBS symptom scale) - You have measurable symptoms of depression, anxiety, or stress on a standard questionnaire - You are over 18 years old - You have a smartphone or computer that can run a video call - You do not have bleeding hemorrhoids, hernia, epilepsy, major heart problems, uncontrolled high blood pressure, severe back pain, or major psychiatric illness, and have not had surgery in the last 3 months **You may NOT be eligible if...** - You are unwilling or unable to attend laughter yoga sessions - You have conditions that make laughter yoga unsafe (e.g., certain heart or pressure conditions) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERlaughter yoga

Patients who come to the outpatient clinic will be met, informed about the study and written informed consent will be obtained from patients who agree to participate in the study. Patient information form will be applied, baseline measurements will be made (IBS-SSS, DAS-42, PSQI and IBS-QOL) and IBS type will be determined according to Bristol stool scale. Type 1-2 constipation, Type 6-7 diarrhea, Type 1 or Type 2 at the same time with Type 6 or Type 7 will be considered as mixed type IBS and those who do not fit any of the scales will be considered as unclassifiable IBS. A total of 8 sessions will be held with the patients in the intervention group in the form of meetings via zoom with the help of a smart cell phone/computer (2 weekly sessions). The meetings will be in 3 groups.